TCL Archive As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray December 13, 2002
TCL Archive Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill September 27, 1996
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive National Action Plan: Return $14 Million To NCI, Committee Tells Shalala February 14, 1997
